CXCL12 and AL amyloidosis: In the GSE4204 dataset, our Kaplan-Meier survival analyses demonstrated that low expression of CXCL12 (p-value: 0.009800177; Figure 3B) and WNT5A (p-value: 0.012647237; Figure 3C) displayed more unfavorable outcomes for multiple myeloma patients.